Helius Medical Technologies Inc Class A (HSDT) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Helius Medical Technologies Inc Class A (HSDT) has a cash flow conversion efficiency ratio of 0.027x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-4.04 Million) by net assets ($-152.39 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Helius Medical Technologies Inc Class A (HSDT) net asset quality to measure how much of total assets are equity-financed.
Helius Medical Technologies Inc Class A - Cash Flow Conversion Efficiency Trend (2013–2024)
This chart illustrates how Helius Medical Technologies Inc Class A's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check earnings quality score of Helius Medical Technologies Inc Class A to evaluate the quality of earnings relative to operating cash generation.
Helius Medical Technologies Inc Class A Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Helius Medical Technologies Inc Class A ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Marchex Inc
NASDAQ:MCHX
|
0.004x |
|
Engenco Ltd
AU:EGN
|
0.101x |
|
Nano X Imaging Ltd
NASDAQ:NNOX
|
-0.110x |
|
Coeptis Therapeutics Inc
NASDAQ:COEP
|
-0.165x |
|
OPAL Fuels Inc
NASDAQ:OPAL
|
0.038x |
|
Loulis Mills S.A.
AT:KYLO
|
0.049x |
|
Thorney Opportunities Ltd
AU:TOP
|
0.039x |
|
JOONGANG DNM Co.Ltd
KQ:051980
|
0.004x |
Annual Cash Flow Conversion Efficiency for Helius Medical Technologies Inc Class A (2013–2024)
The table below shows the annual cash flow conversion efficiency of Helius Medical Technologies Inc Class A from 2013 to 2024. For the full company profile with market capitalisation and key ratios, see Helius Medical Technologies Inc Class A (HSDT) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $1.06 Million | $-11.04 Million | -10.426x | -135.22% |
| 2023-12-31 | $2.35 Million | $-10.42 Million | -4.432x | -152.47% |
| 2022-12-31 | $8.15 Million | $-14.31 Million | -1.756x | -47.60% |
| 2021-12-31 | $11.26 Million | $-13.39 Million | -1.189x | +60.78% |
| 2020-12-31 | $3.87 Million | $-11.74 Million | -3.032x | +15.74% |
| 2019-12-31 | $5.83 Million | $-21.00 Million | -3.599x | -80.74% |
| 2018-12-31 | $9.85 Million | $-19.62 Million | -1.991x | -177.17% |
| 2017-12-31 | $-7.49 Million | $-19.32 Million | 2.580x | -99.47% |
| 2016-12-31 | $-16.19K | $-7.94 Million | 490.176x | -0.01% |
| 2015-12-31 | $-16.19K | $-7.94 Million | 490.206x | +12020.05% |
| 2014-12-31 | $-1.56 Million | $-6.32 Million | 4.045x | +210.83% |
| 2013-12-31 | $-267.98K | $-348.70K | 1.301x | -- |
About Helius Medical Technologies Inc Class A
Solana Company operates as a listed digital asset treasury. It enhances SOL per share on the commercially viable blockchain for decentralized finance and consumer applications. The company is headquartered in Newtown, Pennsylvania.